Artwork

To PASTEUR or not to PASTEUR

Superbugs Unplugged

12 subscribers

published

iconShare
 
Manage episode 353536226 series 2691615
Content provided by Lance Price and Jay Graham, Lance Price, and Jay Graham. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Lance Price and Jay Graham, Lance Price, and Jay Graham or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In our January episode of Superbugs Unplugged, co-hosts Matt Wellington and Louis Sokolow chat with Dr. Reshma Ramachandran, Assistant Professor of Medicine at the Yale School of Medicine and Director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT). First, we hear about Dr. Ramanchandran’s work with CRRIT to ensure that FDA-approved medical products are sufficiently safe and accessible. Next, we do a deep dive into the PASTEUR Act, a piece of legislation that would incentivize antibiotic development through government contracts with companies that receive FDA approval for a new antibiotic. Dr. Ramachandran provides her perspective and walks us through the flaws she sees in the bill, and we wrap up with a discussion of alternatives to PASTEUR. Tune in here to listen to the conversation!

  continue reading

44 episodes